Why Rome's dolphins are fighting each other
Now, a recent study shows that the dolphins are not only sick, but they're fighting over food—and it's due to human activity.
The 'Capitoline dolphins,' as researchers have named them, have inhabited the coast outside Rome for thousands of years, as shown by mosaics from the archaeological site of Ostia Antica that depict the dolphins stealing fish from fishermen's nets 2,000 years ago. Yet they've only recently been closely studied, beginning in 2016.
Around 500 dolphins spend some of the year in the area, while about 100 are permanent residents—mostly females and their offspring who live near the mouth of the Tiber River, where food is most abundant. This makes the area an important breeding site, where males are attracted each year to mate.
Daniela Silvia Pace, a researcher at the Sapienza University of Rome, has studied these dolphins for a decade. She and her colleagues recently analyzed more than 400 photographs taken between 2016 and 2023, depicting 39 individuals of the resident population.
"What emerges is a decidedly worrying picture,' as these animals are subject to so many pressures, she says.
Pace and her team measured and counted marks on the dolphins' bodies. Analyzing marks on cetaceans is a common technique used by scientists, as it can tell them a lot about their life, their health, and the dangers they're exposed to.
The result of the new research, published in Aquatic Conservation: Marine and Freshwater Ecosystems in April, does not necessarily paint a hopeful picture. 'Unfortunately, the situation for bottlenose dolphins in the Mediterranean, including the Tiber River Estuary, appears to be particularly concerning,' says Bruno Díaz López, a biologist and director at Bottlenose Dolphin Research Institute, who was not involved with the study but found it 'very interesting and relevant.'
The analysis revealed that 70 percent of the residents studied showed signs of malnutrition, such as visible ribs. 'This is strange, because we are in an area rich in food,' says Alice Turchi, a PhD student in environmental and evolutionary biology at the Sapienza University of Rome and author of the study. Turchi and her colleagues believe that the lack of food might be due to overfishing.
'The fact that most of the population is undernourished is a strong alarm bell,' adds Pace.
In the study, the lines and ropes used by fishermen had left marks on half of the dolphins' bodies, and amputations were present as well. Nearly all, or 97 percent, of the dolphins had a skin disease, which didn't come as a shock to the researchers.
'It is not surprising,' says Turchi, because the water is tainted, mostly due to pollutants carried by the Tiber River into the sea, as well as wastewater from boats passing through. 'Pollution can promote immunodepression and cause animals to get sick,' Turchi says.
In another distressing development, researchers also found evidence of fighting. They analyzed teeth marks caused by interactions with other dolphins, which were universal across the population. While these marks are sometimes normal for dolphins, as they can bite to communicate dominance during mating competitions or to establish social hierarchies, this population showed an unusually high number. The researchers believe that this may be due to competition for dwindling food resources.
López, from the Bottlenose Dolphin Research Institute, says the findings on the Capitoline dolphins' health 'are consistent with what we observe in many coastal bottlenose dolphin populations worldwide.'
'These populations are exposed to continuous and intense pressure from human activities, ranging from fisheries and maritime traffic to pollution and habitat degradation,' he notes.
For example, he says, 'in Galicia, on the Atlantic coast of Spain, we see similar patterns of skin marks related to both natural and anthropogenic factors.' Similarly, he says, 'studies from other regions—such as Sarasota Bay in the United States or various sites in Australia—also report high frequencies of marks linked to social interactions, fishing gear, boat strikes, and skin diseases.'
While bottlenose dolphins are an adaptable species and can show great resilience, the researchers are worried about the future of this population. The area is currently 'unmanaged,' says Turchi, meaning that almost no conservation actions are carried out to protect this slice of coast. 'There is a need to carry out interventions to safeguard this population, which is unique.'
The team says that it would be necessary to establish a Site of Community Importance, which would help the conservation of this population and the whole rich ecosystem found off this coast. But the process to establish such a site is 'very complex,' says Pace, and would need to run up the political chain.
The researchers hope that making this population known to the general public could be a step in the right direction to ensure that politicians will be more motivated to implement conservation actions aimed at protecting the area.
'It is important to take into account that this area is important for this species, and it is also important for our species,' says Turchi. 'We should try as much as possible to reconcile human exploitation with the conservation of biodiversity.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Tensive appoints medical device veteran Bill Hunter Chairman as its bioresorbable scaffold for breast reconstruction after cancer approaches market
Has more than 30 years of experience bringing innovations to market, including one of the world's first drug-eluting coronary stents at Angiotech Pharma Appointment adds world-class capabilities to Tensive as the company approaches pivotal clinical trial milestones Pivotal trial may enable European and U.S. commercialization of Tensive's innovative bioresorbable REGENERA™ and SOFTAG™ devices for breast reconstruction and tissue marking Tensive published positive first impressions from pivotal trial in April, and from first-in-human trial in 2023 Milan, Italy – August 5, 2025 – Tensive S.r.l, a clinical-stage advanced biomaterials medical device company, and the developer of REGENERA™ and SOFTAG™ bioresorbable scaffolds for breast reconstruction and tissue marking, has appointed Bill Hunter, MD, as Chairman of its Board of Directors. Dr. Hunter brings more than 30 years of leadership in the medical technology and life sciences sectors. His appointment reflects Tensive's focus on strengthening its governance and expanding its global network as it accelerates toward pivotal clinical milestones and commercialization in the U.S. and Europe. Dr. Hunter is the founder and CEO of Canary Medical, a medical data company developing implantable sensor technology. Previously, he founded Angiotech Pharmaceuticals, where he led the development of one of the world's first drug-eluting coronary stents, a multi-billion-dollar innovation that transformed interventional cardiology. 'It's a great honor and validation of the medical potential of Tensive's advanced biomaterials that Bill has accepted to lead our board of directors. His track record of successfully guiding pioneering technologies from concept to commercialization is unmatched,' said Sanjay Kakkar, Chief Executive Officer of Tensive. 'Bill's strategic insights and industry perspectives will be crucial advantages as we complete registrational studies and advance our first device into regulatory processes for marketing approval and commercialization in the U.S. and Europe.' Tensive's innovative polymeric bioresorbable scaffolds allow a natural, non-invasive, permanent and safe solution for breast reconstruction during lumpectomy. In addition, they enable precision tissue marking, demarcating the affected area to direct more targeted radiotherapy and improve imaging accuracy during surveillance and follow-up. 'I am truly excited to join Tensive at such a pivotal moment in its journey,' said Bill Hunter, MD, Chairman of the Tensive Board of Directors. 'In addition to being impressed by the leadership, I became convinced that this was an exceptional opportunity after reviewing the recently published interim data from the ongoing pivotal study of REGENERA™, as well as the excellent long-term follow-up data from the first-in-human clinical trial. The enthusiasm expressed by the key opinion leaders involved with the clinical studies further confirmed my impression of the data. I look forward to supporting Sanjay and his experienced team at Tensive as they bring REGENERA™ and SOFTAG™ to the market.' REGENERA™ / SOFTAG™ advanced biomaterial is a bioresorbable implant designed to be placed during lumpectomy surgery. The bioresorbable medical device is gradually absorbed by the body and enables the patient's own tissue to regrow in the area it fills. The result is breast restoration composed of natural tissue that preserves the patient's original breast shape and feel, yet is clearly differentiated from surrounding tissues on imaging, supporting more targeted delivery of radiotherapy and more accurate monitoring for potential recurrence. The biomaterial used in REGENERA™ and SOFTAG™ resembles a sponge with a fine scaffold matrix; its placement during the lumpectomy surgery is a one-step, minimally invasive, rapid and easy-to-adopt procedure. Currently, patients undergoing benign and malignant lumpectomy do not typically receive cosmetic intervention to prevent breast disfigurement, which can be psychologically devastating. Of the 2.1 million lumpectomies performed worldwide each year, 1.9 million are not reconstructed, constituting a sizeable unmet clinical need [1]. Despite the psychological impact of breast disfigurement following lumpectomy, more common cosmetic surgery options are rarely used, because they entail invasive and complex procedures that often fail to achieve the desired outcome. Preliminary data from the first 16 patients in Tensive's ongoing multi-center pivotal trial in 94 patients undergoing malignant lumpectomy were published in Updates in Surgery in April 2025, with investigators writing: 'In conclusion, we are convinced that REGENERA™ could represent a great innovation in breast oncological surgery, representing a possible alternative to volume replacement with faster operative time, faster recovery, less morbidity, and good patient satisfaction [2].' These results followed the publication in Breast Cancer in 2023 of six-month follow-up data from five patients in a first-in-human trial that demonstrated positive outcomes in terms of both safety and performance, leading the clinical investigators who authored the paper to conclude that the data were 'paving the way to an innovative approach with a potential remarkable impact on clinical application of tissue engineering [3].' [1] Analysis based on estimates from the International Society of Aesthetic Plastic Surgery (ISAPS), Breast Cancer Research Foundation (BCRF), the American College of Surgeons (ACS), the World Health Organization (WHO) and Global Market Insights.[2] A.V.E. Lisa et al. Updates in Surgery Apr 2025. Mariniello et al. Breast Cancer 2023. S.r.l. ( is a clinical-stage advanced biomaterials medical device company developing bioresorbable polymeric scaffolds for breast reconstruction and tissue marking. Its patented REGENERA™ biomimetic scaffold is designed to allow regeneration of a patient's own breast tissue to create natural, safe, and lasting reconstruction for patients recovering from lumpectomy or undergoing cosmetic procedures, while its SOFTAG™ precision tissue marking device enables more targeted delivery of radiotherapy and increases the accuracy of surveillance and follow-up. Tensive's mission is to improve clinical outcomes and the quality of life for women worldwide through accessible, innovative, and sustainable solutions. For more information please contact: Tensive Srl Cohesion Bureau media@ Italian and international media & investorsGiovanni Ca' Zorzitensive@ 7 8467 0727 Attachment 20250805 Tensive PR Bill Hunter appointment (final)Error in retrieving data Sign in to access your portfolio Error in retrieving data

WIRED
a day ago
- WIRED
A Hiker Was Missing for Nearly a Year—Until an AI System Recognized His Helmet
Aug 4, 2025 5:30 AM Using AI to analyze thousands of frames taken by drone, a mountain rescue team has found the body of a doctor who had been missing since September 2024. Drone on Monviso locating the body of a missing hiker. Photo: CNSAS How long does it take to identify the helmet of a hiker lost in a 183-hectare mountain area, analyzing 2,600 frames taken by a drone from approximately 50 meters away? If done with a human eye, weeks or months. If analyzed by an artificial intelligence system, one afternoon. The National Alpine and Speleological Rescue Corps, known by it's Italian initialism CNSAS, relied on AI to find the body of a person missing in Italy's Piedmont region on the north face of Monviso—the highest peak in the Cottian Alps—since September 2024. According to Saverio Isola, the CNSAS drone pilot who intervened along with his colleague Giorgio Viana, the operation—including searching for any sign of the missing hiker, the discovery and recovery of his body, and a stoppage due to bad weather—lasted less than three days. The Recovery Operations With his back to the ground, his gaze fixed on the mountains, 600 meters below the summit, the body of 64-year-old Ligurian doctor Nicola Ivaldo was found on the morning of Thursday, July 31, more than 10 months after his disappearance, thanks to his helmet that clashed with the rest of the landscape. "It was the AI software that identified some pixels of a different color in the images taken on Tuesday," explains Isola, reconstructing step-by-step the operation that led to the discovery and recovery of the remains located at an altitude of approximately 3,150 meters, in the rightmost of the three ravines that cut through the north face of Monviso, above a hanging glacier. The team collected all the images in five hours with just two drones on the morning of Tuesday, July 29, and analyzed them using AI software during the afternoon of the same day. By that evening, the rescuers already had a series of "suspicious spots" to check. Only fog and bad weather the following day delayed the operations. "We woke up at 4 am to reach a very distant point with good visibility on the channel where the red pixels had been detected, and we used the drone to see if it was indeed the helmet," says Isola. "Then we took all the necessary photos and measurements, sending the information to the rescue coordination center, which was then able to dispatch the Fire Brigade helicopter for the recovery and police operations." The Role of AI Every drone operation is part of a rigorous method developed by CNSAS in coordination with ENAC, the national agency that oversees civil aviation. "We've been using drones for about five years, and for about a year and a half we've been integrating color and shape recognition technologies, developing them month by month," Isola explains. "But all of this would be useless without the teams of technicians." Information from Ivaldo's cell phone was immediately invaluable. The two drone pilots who navigated the area were aided by the experience and knowledge of four expert mountain rescuers. "It's a human achievement, but without technology, it would have been an impossible mission. It's a team success," said Isola. Isola, his colleague Viana, and the few other "select pilots" from the CNSAS know well how crucial technology can be if used properly. "Even in the recovery operations following the Marmolada Glacier tragedy, it allowed us to operate in inaccessible areas and recover all the necessary artifacts," Isola recalls. "It prevented the rescuers from risking their lives." The CNSAS goal is further collaboration between artificial intelligence and drones to prevent the most serious consequences of mountain accidents and save missing people while they are still alive. This combination can also be used to obtain and analyze information with thermal imaging cameras, which are sensitive only to living beings. "Just like with still images, AI is also able to interpret thermal data and provide valuable information in just a few hours," Isola explains. "In Sardinia, a colleague recently rescued some climbers whose ropes were stuck on a rock face and was able to locate them only thanks to the drone and other technologies that are part of our method. Many of them are from wartime; we have recovered and converted them." The hope is that, with ever-increasing use, the number of fatal mountain accidents can be drastically reduced. This story originally appeared on WIRED Italy and has been translated from Italian.
Yahoo
a day ago
- Yahoo
Ten deaths reported from West Nile virus in Italy since the start of the year
The death toll from the West Nile virus in Italy since the beginning of the year rose to ten after a 93-year-old woman died at the Spallanzani Institute in Rome. It was the fourth cased verified in the Lazio region. The patient, originally from Cisterna di Latina, had been admitted to San Paulo in Velletri before being transferred to Rome. Three other deaths from the virus were reported last Wednesday. This includes a 76-year-old man from Salerona, a 73-year-old man from Maddaloni and an 86-year-old who was admitted to the Santa Maria Goretti hospital in Latina. He was among the first infected in the area and reportedly suffered with several previous diseases. In its latest report on Thursday, the Italian National Institute of Health reported the following data. It said 57 new human cases of West Nile virus were reported between the 24th and 30th of July. Among the confirmed cased, eight deaths were reported. The lethality rate of the neuro-invasive form of the virus is 20% in 2025 compared to 14% in 2024 and 20% in 2018. Data on West Nile fever in Europe The European Centre for Disease Prevention and Control released the latest data on infections in Europe on Thursday. Cases were registered in Italy, Greece, Romania, Bulgaria and France. 25 cases of locally acquired West Nile virus infection were reported for the first time in the 2025 transmission season in one region each in Bulgaria and France. Compared to the previous week, Greece reported cases of West Nile virus infection in three new regions, Italy in seven new regions and Romania in one new region. The highest number of cases (43) was reported in the province of Latina, Italy. What is West Nile fever and how to prevent it West Nile fever causes high fever and rashes. It is a globally widespread viral diseased caused by the West Nile virus. The main hosts of the virus are usually wild birds. Transmission to humans occurs mainly through mosquito bites. In rare cases, it can occur through transplants, transfusion or from mother to foetus. It is not transmitted from person to person through physical contact. Other mammals such as horses and, to a lesser extent, dogs and cats, can also be infected. The incubation period lasts from two to 14 days. Most infected people do not show any symptoms. About 20% develop mild symptoms such as fever, headache, nausea and skin rashes, which usually disappear on their own within a few days. In less than 1% of cases, symptoms can be severe. This includes high fever, disorientation, tremors and, in the most serious cases, paralysis and coma. Diagnosis is made by laboratory tests that look for antibodies in serum or cerebrospinal fluid. There is no vaccine or specific treatment for West Nile fever. Treatment is aimed at managing the symptoms, and in severe cases, hospitalisation may be necessary. Prevention is the only effective strategy and is based on reducing exposure to mosquito bites. It is advised to use insect repellents, wear protective clothing, install mosquito nets and remove still water from containers to prevent mosquito breeding.